Nikitin, P. I. | bioRxiv Science

bioRxiv2026

Development of approaches to overcome the drop in hematocrit when implementing mononuclear phagocyte system cytoblockade in vivo used to prolong the circulation of nanoparticles in the blood

While engineered nanomaterials offer unprecedented precision in targeting tumor cells, their efficacy is often limited by rapid clearance from the bloodstream via the mononuclear phagocyte system (MPS). To overcome this limitation, a promising strategy known as MPS-cytoblockade has been developed. This approach involves administering antibodies against host erythrocytes. The resulting saturation of the MPS with erythrocyte clearance creates a critical window, allowing subsequently administered nanoparticles to evade immune surveillance and circulate for a significantly extended period. However, MPS-cytoblockade induces a transient reduction in hematocrit, which can lead to adverse effects. Here, we demonstrate that approaches to restore hematocrit, specifically through the administration of donor erythrocyte suspension or the hormone erythropoietin, effectively prevent this drop while maintaining the efficacy of the MPS-cytoblockade. Notably, these interventions do not compromise the prolonged circulation time of the nanoparticles or alter their biodistribution, preserving high accumulation in tumors. Our findings establish a viable strategy to mitigate a key side effect of MPS-cytoblockade, thereby enhancing its therapeutic potential and safety profile.

pharmacology and toxicology↗

bioRxiv2026

What Do Biological Foundation Models Compute? Sparse Autoencoders from Feature Recovery to Mechanistic Interpretability

Foundation models trained on protein and DNA sequences are increasingly deployed for variant interpretation, drug design, and gene regulation prediction, yet their internal representations remain opaque - limiting both biological insight and trust in model-guided decisions. Existing interpretation approaches establish what these models encode but cannot reveal how biological knowledge is internally organized and computed. Sparse autoencoders (SAEs) offer a complementary approach by decomposing model activations into interpretable features, each capturing a distinct biological concept. Over the past year, SAEs have been applied to protein language models, genomic language models, pathology vision transformers, single-cell foundation models, and protein structure generators. Here we provide a systematic review of sparse dictionary learning across biological foundation models. We find that independent studies using different architectures and evaluation strategies consistently recover features spanning biological scales - from secondary structure elements and functional domains in proteins to transcription factor binding sites and regulatory elements in genomes - providing convergent evidence that these models learn interpretable representations accessible through sparse decomposition. However, we identify a critical gap: validation relies almost exclusively on matching features against existing annotations, risking circularity when those annotations derive from the same sequence databases used for model training. We propose a three-level interpretability framework - representational, computational, and causal mechanistic - and argue that the fields most distinctive opportunity lies in experimental validation through deep mutational scanning, massively parallel reporter assays, and structural characterization, which can establish whether these models have learned genuine biological mechanisms rather than training set statistics.

bioinformatics↗